Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL515728 | 1.00 | EPHX2 (0.41) | EPHX2MEN1KMT2AFFAR4FFAR1 | |
| SCHEMBL15977917 | 1.00 | EPHX2 (0.41) | EPHX2MEN1KMT2AFFAR4FFAR1 | |
| SCHEMBL7914906 | 1.00 | EPHX2 (0.41) | EPHX2MEN1KMT2AFFAR4FFAR1 | |
| SCHEMBL788641 | 1.00 | EPHX2 (0.41) | EPHX2MEN1KMT2AFFAR4FFAR1 | |
| SCHEMBL25206528 | 1.00 | EPHX2 (0.41) | EPHX2MEN1KMT2AFFAR4FFAR1 | |
| SCHEMBL23234144 | 1.00 | EPHX2 (0.41) | EPHX2MEN1KMT2AFFAR4FFAR1 | |
| SCHEMBL18970877 | 1.00 | EPHX2 (0.41) | EPHX2MEN1KMT2AFFAR4FFAR1 | |
| SCHEMBL23016820 | 1.00 | EPHX2 (0.41) | EPHX2MEN1KMT2AFFAR4FFAR1 | |
| SCHEMBL61278 | 1.00 | EPHX2 (0.41) | EPHX2MEN1KMT2AFFAR4FFAR1 | |
| SCHEMBL31314689 | 1.00 | EPHX2 (0.41) | EPHX2MEN1KMT2AFFAR4FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 694 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025097289-A1 | COMPOSITION FOR CARING FOR KERATIN MATERIALS | L'OREAL (FR) | 2025-05-15 | — | — | WO | claimed |
| EP-3134065-B1 | COMPOSITION IN THE FORM OF NANO- OR MICRO- EMULSION | OREAL (FR) | 2021-04-21 | — | — | EP | claimed |
| US-10561587-B2 | Composition in the form of nano- or micro-emulsion | L'OREAL (FR) | 2020-02-18 | — | — | US | claimed |
| US-20170156998-A1 | COMPOSITION IN THE FORM OF NANO- OR MICRO-EMULSION | L'OREAL (FR) | 2017-06-08 | — | — | US | claimed |
| EP-3134065-A1 | COMPOSITION IN THE FORM OF NANO- OR MICRO- EMULSION | L'OREAL (FR) | 2017-03-01 | — | — | EP | claimed |
| WO-2015152420-A1 | COMPOSITION IN THE FORM OF NANO- OR MICRO- EMULSION | L'OREAL (FR) | 2015-10-08 | — | — | WO | claimed |
| EP-1842528-B1 | Cosmetic composition comprising at least one hydroxy acid, at least one mono- or disaccharide and at least one ceramide, and process for the preparation thereof | ORÉAL L (FR) | 2015-04-15 | — | — | EP | claimed |
| EP-0774248-B2 | Keratinous fiber treating composition containing at least a binding polymer and at least a ceramide-type compound and methods | OREAL (FR) | 2014-03-12 | — | — | EP | claimed |
| US-7914775-B2 | Treating keratinous fibres, in particular human keratinous fibres such as hair, comprising in a physiologically acceptable medium, at least a protecting or conditioning agent, and further at least a cationic associative | L'OREAL S.A. (FR) | 2011-03-29 | — | — | US | claimed |
| EP-1312335-B1 | Cosmetic compositions containing aminosilicone and a conditioning agent and their use | OREAL (FR) | 2010-08-11 | — | — | EP | claimed |
| US-6039962-A | COSMETICS WITH AMIDE GROUPS IN WATER | L'OREAL (FR) | 2000-03-21 | — | — | US | claimed |
| EP-0774248-B1 | Keratinous fiber treating composition containing at least a binding polymer and at least a ceramide-type compound and methods | OREAL (FR) | 1999-02-10 | — | — | EP | claimed |
| US-5830481-A | Cosmetic compositions containing a lipid ceramide compound and a peptide having a fatty chain, and their uses | L'OREAL (FR) | 1998-11-03 | — | — | US | claimed |
| EP-0862405-A1 | COMPOSITION FOR TREATING KERATINOUS MATERIAL, INCLUDING AT LEAST ONE SILICONE-GRAFTED POLYMER AND AT LEAST ONE FATTY-CHAIN AMIDE, AND USES THEREOF | L'OREAL (FR) | 1998-09-09 | — | — | EP | claimed |
| EP-0852134-A1 | Use of a composition containing a ceramide and a sulphonic UV filter | L'OREAL (FR) | 1998-07-08 | — | — | EP | claimed |
| EP-0704200-B1 | Cosmetic compositions containing a lipid ceramide-type compound and a peptide with a fatty chain | OREAL (FR) | 1997-07-23 | — | — | EP | claimed |
| EP-0774248-A1 | Keratinous fiber treating composition containing at least a binding polymer and at least a ceramide-type compound and methods | L'OREAL (FR) | 1997-05-21 | — | — | EP | claimed |
| WO-1997015274-A1 | KERATIN FIBRE TREATMENT COMPOSITION INCLUDING AT LEAST ONE SETTING POLYMER AND AT LEAST ONE CERAMIDE-TYPE COMPOUND, AND METHODS | L'OREAL (FR) | 1997-05-01 | — | — | WO | claimed |
| WO-1997012587-A1 | COMPOSITION FOR TREATING KERATINOUS MATERIAL, INCLUDING AT LEAST ONE SILICONE-GRAFTED POLYMER AND AT LEAST ONE FATTY-CHAIN AMIDE, AND USES THEREOF | L'OREAL (FR) | 1997-04-10 | — | — | WO | claimed |
| EP-0699430-B1 | Method of hair treatment using amides containing fatty chains and steam | OREAL (FR) | 1996-10-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10561587-B2 | Composition in the form of nano- or micro-emulsion | SGMS2, LIPA, CERS2 | EPHX2 927/4885MEN1 834/4885KMT2A 2397/4885 |
| US-20170156998-A1 | COMPOSITION IN THE FORM OF NANO- OR MICRO-EMULSION | SGMS2, LIPA, CERS2 | EPHX2 927/4885MEN1 834/4885KMT2A 2397/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.